Nykode Therapeutics
NYKD.OL
$1.37
Share price
-0.41%
Change (1 day)
-42.75%
Change (1 year)
Categories
Nykode Therapeutics (NYKD.OL) - P/B ratio
P/B ratio as of May 2024 : 2.61
According to Nykode Therapeutics's latest financial reports the company has a price-to-book ratio of 2.61.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Nykode Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.02 | -24.77% |
| 2022-12-31 | 5.34 | -60.96% |
| 2021-12-31 | 13.7 | -2.24% |
| 2020-12-31 | 14.0 |